Status:
UNKNOWN
Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)
Eligibility:
All Genders
20-80 years
Brief Summary
Participants were randomised to receive benzalkonium chloride-containing latanoprost (Xalatan) or preservative-free bimatoprost (Lumigan). Through this study, the investigators would like to analyze t...
Detailed Description
The purpose of our study is to assess the effect of antiglaucoma medication on ocular surface disease in glaucoma patients before and after treatment with different antiglaucoma medication. All includ...
Eligibility Criteria
Inclusion
- Patients are not diagnosed with glaucoma and don't receive any ocular hypotensive eye drops at our clinic.
- Patients accept the rules for follow-up visits for at least six months.
Exclusion
- Patients are with a history of ocular trauma.
- Patients are with contact lens use.
- Patients are diagnosed with secondary glaucoma.
- Patients have significant diseases affecting the meibomian gland and ocular surface.
- Patients have poor IOP control that required additional ocular hypotensive eye drops.
Key Trial Info
Start Date :
October 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04896125
Start Date
October 2 2019
End Date
August 31 2022
Last Update
May 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100